Viewing Study NCT00138632


Ignite Creation Date: 2025-12-24 @ 9:30 PM
Ignite Modification Date: 2025-12-28 @ 1:37 PM
Study NCT ID: NCT00138632
Status: COMPLETED
Last Update Posted: 2008-11-14
First Post: 2005-08-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)
Sponsor: Novartis
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CPTK787E2201
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: External Affairs
Old Organization: Novartis Pharmaceuticals

Collaborators